PF-05105679

DB15450InvestigationalSmall molecule

PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679).

Chemical structure of PF-05105679
Formula / weight
C26H21FN2O3 · 428.463 g/mol (avg)
Code names
PF-05105679

Resolves to

Compound
UNIIF2B10OFV7YCAS1398583-31-7ChEMBLCHEMBL3577885
Structure
InChIKeyBXNMZRPTQFVRFA-QGZVFWFLSA-NSMILESC[C@@H](N(CC1=CC(=CC=C1)C(O)=O)C(=O)C1=CC2=C(C=CC=C2)N=C1)C1=CC=C(F)C=C1
Targets
Q7Z2W7TRPM8

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with PF-05105679, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In